Sign in
Not yet taking people in SpainPhase 4

Injections near the shoulder muscles for trapezius pain in fibromyalgia

Tests injected bupivacaine and triamcinolone against saline for trapezius pain in fibromyalgia.

Key facts

Who runs it
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Where
Barcelona, SpainSee the site
Registry title
LOCAL INVASIVE TREATMENT OF TRAPEZIUS MUSCLE PAIN IN PATIENTS WITH FIBROMYALGIA
Status
Not yet recruiting
Phase
Phase 4
People taking part
69 people, planned
Started
26 Jun 2023
Planned end
26 Jun 2025
Type of study
Interventional
Record updated
15 January 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with fibromyalgia who have long-lasting pain in the trapezius muscle (upper back and shoulder). It compares bupivacaine/triamcinolone injections with saline or placebo, given with ultrasound guidance.

Age
18 Years to 64 Years
Sex
All sexes can join.
Disease stage
Fibromyalgia diagnosed by ACR 1990 and ACR 2010 criteria. Constant pain in the right and/or left upper trapezius for more than three months. Tight bands and trigger points found on exam. Local pain score greater than 3 on VAS and overall pain score greater than 3.
Earlier treatment
No new treatment, or a stable treatment, in the last three months. In the last three months, people may have used weak opiates (tramadol or codeine), paracetamol or metamizol as rescue or prescribed medicine. People who had this type of procedure before cannot join. No chronic corticosteroids or strong opiates in the 3 months before joining.

Main reasons for not taking part

  • New pain drug or changed dose in the last three months
  • Problems with blood clotting, or taking anticoagulants (blood thinners)
  • Past surgery on the neck spine or shoulders, or active neck, back, shoulder joint or tendon disease
  • Allergy or intolerance to bupivacaine, other local anesthetics or triamcinolone acetonide
  • Pregnant or breastfeeding

The registry criteria, word for word

Show all 21 criteriaShow less

Who can take part

  • Patients Over 18 years old
  • Patients who suffer from Fibromyalgia, diagnosed with ACR 1990 criteria and ACR 2010 criteria
  • Patients who have not started a new treatment, or patients who recieve a stable treatment in the last three months
  • Patients who, in the last three months, have received treatment with weak opiates (tramadol or codeine), paracetamol or metamizol as rescue medication, on demand, or as prescribed
  • Presence of spontaneous, continuous pain in the right and/or left upper trapezius lasting more than three months, with palpable bands on examination as well as trigger points in the trapezius, with a local pain intensity scale greater than 3 , according to VAS and generalized pain scale greater than 3
  • Signature of the informed consent

Who cannot take part

  • Patients who have previously undergone this type of procedure
  • Patients who, in the three months prior to inclusion, have received chronic treatment with corticosteroids or strong opiates
  • Altered coagulation and patients treated with anticoagulants
  • Presence of other uncontrolled metabolic, endocrinological, cardiovascular and visceral diseases
  • Presence of skin lesions, eczema, skin infections in the drug administration area (trapezius)
  • Presence of psychiatric disorders that interfere with the adequate understanding of the treatment to be carried out or of the questionnaires (for example, psychosis or dementia)
  • Patients who have been prescribed a new drug for their chronic pain condition or whose dose has been modified in the last three months (including antidepressants, anticonvulsants...)
  • Presence of other uncontrolled infectious, metabolic or inflammatory neuromuscular diseases
  • History of surgery on the cervical spine and/or shoulders
  • Presence of active spinal disease in the cervical and/or dorsal segments
  • Presence of active tendon or joint disease affecting the shoulders
  • Intolerance, hypersensitivity or allergy to Bupivacaine or other local anesthetics
  • Intolerance, hypersensitivity or allergy to triamcinolone acetonide
  • Implanted electrical devices for pain management (neuromodulation)
  • Pregnant or breastfeeding patients

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

Where in Spain

  • Hospital Clinic de BarcelonaBarcelona, SpainNot yet recruiting

About the trial

What the trial wants to find out

To compare the efficacy in improving pain, both locally and generalized, in patients with fibromyalgia who present myofascial trapezius pain syndrome, as well as its duration, after regional administration of bupivacaine/triamcinolone vs physiological saline vs placebo. , in the interfascial space between the trapezius and supraspinatus muscles and between the trapezius and levator scapulae muscles.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Official title
EFFICACY AND SAFETY OF LOCAL TREATMENT OF TRAPEZIUS MYOFASCIAL SYNDROME IN PATIENTS WITH FIBROMYALGIA THROUGH ULTRASOUND-GUIDED INTERFASCIAL BLOCK OF THE TRAPEZIUS MUSCLE
Plain-language title
Injections near the shoulder muscles for trapezius pain in fibromyalgiaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from 2024-520345-23-00, who can take part
Record updated
15 January 2025